AI assistant
Sending…
TENAX THERAPEUTICS, INC. — Director's Dealing 2021
Jun 15, 2021
34835_dirs_2021-06-15_d499c42c-0a20-484a-8476-98c54f301e93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2021-02-25
Reporting Person: Doogan Declan (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 567871 | Direct |
| Series B Preferred Stock | 3070 | Direct |
More from TENAX THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Share Issue/Capital Change
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
May 9
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22